Influencing and shaping our sector | BIA update: July - October 2020

This quarterly update gives an overview of key policy developments and the BIA’s continued engagement with policymakers, regulatory authorities and wider stakeholders on behalf of the UK life sciences sector, from July to October 2020.

Biotech financing update June to August 2020.pdf

BIA response to HMT consultation on Preventing abuse of the R&D tax relief for SMEs second consultation

The BIA has responded to a second consultation on the proposed PAYE cap on R&D tax credits.

BIA submission to the Comprehensive Spending Review 2020

BIA response to the R&D Roadmap

The BIA has responded to the Government's consultation on its R&D Roadmap.

Advice on employee inventor compensation in the UK following Shanks v Unilever

Prepared by Will James of Osborne Clarke with support from other members of the BIA IP Advisory Committee

Influencing and shaping our sector BIA update Q2 2020

The BioIndustry Association (BIA)’s ongoing engagement enables our members’ voices to be heard at the highest levels. This quarterly update gives an overview of key policy developments and the BIA’s continued engagement with policymakers, regulatory authorities and wider stakeholders on behalf of the UK life sciences sector, from April to July 2020.

BIA submission to the PAC inquiry on management of tax reliefs

The BIA has submitted evidence on the effectiveness of R&D tax credits to the House of Commons Public Accounts Committee inquiry on the management of tax reliefs.

BIA submission to the 2020 Labour Economy Business and Trade Commission

The BIA has submitted views to the 2020 Labour Party National Policy Forum commission on the economy, business and trade.

BIA submission to the 2020 Labour Health Commission

The BIA has submitted views to the 2020 Labour Party National Policy Forum commission on health and social care.